Your browser doesn't support javascript.
loading
Pulmonary interstitial lymphography: A prospective trial with potential impact on stereotactic ablative radiotherapy planning for early-stage lung cancer.
Ko, Ryan B; Abelson, Jonathan A; Fleischmann, Dominik; Louie, John D; Hwang, Gloria L; Sze, Daniel Y; Schüler, Emil; Kielar, Kayla N; Maxim, Peter G; Le, Quynh-Thu; Hara, Wendy H; Diehn, Maximilian; Kothary, Nishita; Loo, Billy W.
Affiliation
  • Ko RB; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA; Oakland University William Beaumont School of Medicine, Auburn Hills, MI, USA. Electronic address: ryanko@oakland.edu.
  • Abelson JA; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA; Coastal Radiation Oncology, San Luis Obispo, CA, USA. Electronic address: jonathan.abelson@21co.com.
  • Fleischmann D; Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA.
  • Louie JD; Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA.
  • Hwang GL; Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA.
  • Sze DY; Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA.
  • Schüler E; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA; Department of Radiation Physics, Division of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Kielar KN; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA; Varian Medical Systems, Stanford, CA, USA.
  • Maxim PG; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA; Department of Radiation Oncology, University of California, Irvine, CA, USA.
  • Le QT; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Hara WH; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA.
  • Diehn M; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Kothary N; Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: kothary@stanford.edu.
  • Loo BW; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: BWLoo@stanford.edu.
Radiother Oncol ; 191: 110079, 2024 02.
Article de En | MEDLINE | ID: mdl-38163486
ABSTRACT
This prospective feasibility trial investigated pulmonary interstitial lymphography to identify thoracic primary nodal drainage (PND). A post-hoc analysis of nodal recurrences was compared with PND for patients with early-stage lung cancer; larger studies are needed to establish correlation. Exploratory PND-inclusive stereotactic ablative radiotherapy plans were assessed for dosimetric feasibility.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Radiochirurgie / Tumeurs du poumon Limites: Humans Langue: En Journal: Radiother Oncol / Radiother. oncol / Radiotherapy and oncology Année: 2024 Type de document: Article Pays de publication: Irlande

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Radiochirurgie / Tumeurs du poumon Limites: Humans Langue: En Journal: Radiother Oncol / Radiother. oncol / Radiotherapy and oncology Année: 2024 Type de document: Article Pays de publication: Irlande